Mineralocorticoid Receptor Antagonism Prevents Aortic Plaque Progression and Reduces Left Ventricular Mass and Fibrosis in Patients With Type 2 Diabetes and Chronic Kidney Disease: The MAGMA Trial
Hypokalaemia in patients with type 2 diabetes and chronic kidney disease: the effect of finerenoneâ€”a FIDELITY analysis
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
